Spacecraft

CATUG and Crystal Bio Establish Strategic Partnership, Launching "CATUG-Crystal" Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services

Retrieved on: 
Thursday, February 22, 2024

and CRANBURY, N.J., Feb. 22, 2024 /PRNewswire/ -- CATUG Inc. (CATUG) and Crystal Bio, a member of Crystal Pharmatech, announced today a long-term strategic partnership to provide advanced nucleic acid-based drug analytical services.

Key Points: 
  • and CRANBURY, N.J., Feb. 22, 2024 /PRNewswire/ -- CATUG Inc. (CATUG) and Crystal Bio, a member of Crystal Pharmatech, announced today a long-term strategic partnership to provide advanced nucleic acid-based drug analytical services.
  • CATUG, a distinguished global entity specializing in integrated nucleic acid and drug delivery CRDMO services, is combining capabilities with Crystal Bio, a premier provider of analytical services for biologics in CMC, preclinical development, and clinical stages.
  • The two specialized organizations will provide clients with comprehensive nucleic acid services and analytical solutions in the North American market.
  • CATUG and Crystal Bio are confident that by combining the local analytical prowess of Crystal Bio with CATUG's proficient expertise in integrated nucleic acids analytical platforms, CATUG-Crystal will deliver best-in-class analytical services and drive advancements in nucleic acid-based drug development to the North American market.

NASA Invites Media to First Astronaut Launch Aboard Boeing's Starliner

Retrieved on: 
Wednesday, February 21, 2024

NASA astronauts Butch Wilmore and Suni Williams will launch aboard Starliner on a United Launch Alliance Atlas V rocket and dock at the orbiting laboratory, where they will stay for up to two weeks.

Key Points: 
  • NASA astronauts Butch Wilmore and Suni Williams will launch aboard Starliner on a United Launch Alliance Atlas V rocket and dock at the orbiting laboratory, where they will stay for up to two weeks.
  • Liftoff is currently targeted for mid-April 2024 from Space Launch Complex-41 at Cape Canaveral Space Force Station in Florida.
  • The mission will test the end-to-end capabilities of the Starliner system, including launch, docking, and return to Earth in the desert of the western United States.
  • Following a successful mission, NASA will begin the final process of certifying Starliner and systems for crewed missions to the space station.

SPACE PERSPECTIVE UNVEILS THE FUTURE OF HUMAN SPACE TRAVEL

Retrieved on: 
Tuesday, February 20, 2024

CAPE CANAVERAL, Fla., Feb. 20, 2024 /PRNewswire/ -- Space Perspective, the world's first carbon-neutral spaceflight experience company, released images of its completed test capsule today. With its first SpaceBalloon finished and its launch vessel, Marine Spaceport Voyager, in its final stage of preparation, Space Perspective is beginning to eye its test flights window.

Key Points: 
  • "The space capsule is like nothing the world has ever seen," said MacCallum, who is also Space Perspective's CTO, noting the capsule's massive windows, iconic design, and spacious interior.
  • We are redefining the category and paving the way for accessible space travel for years to come."
  • Space Perspective also long considered repeated vertical windows, which allow for contiguous panoramic views (vs. horizontal windows, which would bifurcate the view to the human eye – a phenomenon resulting from stereoscopic vision).
  • Space Perspective is on a mission to bring more humans to space than ever before.

Lonestar marks the successful Launch of its first Lunar Data Center Test Mission, "Independence", Flying To The Moon With Intuitive Machines on their IM-1 Mission

Retrieved on: 
Monday, February 19, 2024

This landmark mission represents a significant milestone in Lonestar's ambitious vision to use the Moon to secure Earth's data.

Key Points: 
  • This landmark mission represents a significant milestone in Lonestar's ambitious vision to use the Moon to secure Earth's data.
  • Throughout the flight to the Moon, Lonestar's Independence payload will undergo a series of critical in-flight tests, designed to validate Lonestar's innovative data center concept for Disaster Recovery as a Service (DRaaS).
  • These tests are essential for ensuring the viability of lunar data centers as a reliable and secure solution for data backup and restoration on a global scale.
  • We are grateful for the support of our partners, stakeholders, and the global community as we embark on this unprecedented venture.

Rocket Lab Prepares to Bring In-Space Manufacturing Capsule Back to Earth for Varda Space Industries

Retrieved on: 
Thursday, February 15, 2024

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a leading launch and space systems company, today announced that the Federal Aviation Administration (FAA) has approved the reentry of Varda Space Industries’ (“Varda”) in-space manufacturing capsule, enabling Rocket Lab to commence a series of complex in-space maneuvers and de-orbit burns on the Rocket Lab-built and operated satellite currently hosting the capsule on orbit.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a leading launch and space systems company, today announced that the Federal Aviation Administration (FAA) has approved the reentry of Varda Space Industries’ (“Varda”) in-space manufacturing capsule, enabling Rocket Lab to commence a series of complex in-space maneuvers and de-orbit burns on the Rocket Lab-built and operated satellite currently hosting the capsule on orbit.
  • In the coming days, Rocket Lab will conduct a series of maneuvers to bring the capsule, named Winnebago-1, back to Earth.
  • This mission is the first of four which will use identical Rocket Lab spacecraft to support Varda’s in-space manufacturing.
  • Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success.

Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024

Retrieved on: 
Thursday, February 15, 2024

WILMINGTON, Del., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported its financial results for the fiscal year ended December 31, 2023, and outlined key objectives for 2024.   

Key Points: 
  • “Our partnership with AbCellera represents a strategic step to expand our pipeline, based on our core competencies in medicinal chemistry, cancer biology and clinical development.
  • A second cohort of patients with AML is expected to initiate in the first half of 2024.
  • Under the terms of the agreement, Prelude and AbCellera will jointly discover, develop, and commercialize products emerging from the collaboration.
  • The decrease in general and administrative expenses was primarily due to our continued management of general and administrative expenses.

NASA Artemis Science, First Intuitive Machines Flight Heads to Moon

Retrieved on: 
Thursday, February 15, 2024

Through this flight to the Moon, they will provide insights into the lunar surface environment and test technologies for future landers and Artemis astronauts.

Key Points: 
  • Through this flight to the Moon, they will provide insights into the lunar surface environment and test technologies for future landers and Artemis astronauts.
  • At 1:05 a.m. EST on Thursday, Intuitive Machines' Nova-C lander launched on a SpaceX Falcon 9 rocket from Launch Complex 39A at the agency's Kennedy Space Center in Florida.
  • Once on the Moon, NASA instruments will focus on investigating space weather/lunar surface interactions and radio astronomy.
  • The NASA science aboard will spend approximately seven days gathering valuable scientific data about Earth's nearest neighbor, helping pave the way for the first woman and first person of color to explore the Moon under Artemis.

Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers

Retrieved on: 
Thursday, February 15, 2024

Lantern Pharma Inc. (NASDAQ: LTRN), a leader in AI-driven cancer drug discovery and development, announced an important milestone in its antibody-drug conjugate (ADC) program.

Key Points: 
  • Lantern Pharma Inc. (NASDAQ: LTRN), a leader in AI-driven cancer drug discovery and development, announced an important milestone in its antibody-drug conjugate (ADC) program.
  • In collaboration with Bielefeld University, Lantern has generated a new class of highly specific and highly potent ADCs with a cryptophycin drug-payload.
  • View the full release here: https://www.businesswire.com/news/home/20240215526567/en/
    Preclinical results from Lantern's cryptophycin ADC (Cp-ADC) in HER2 expressing cancers in comparison with commercially available MMAE payload antibody-drug conjugates (ADCs).
  • These efforts aim to improve ADC development for specific patient populations and potentially guide more effective future clinical treatments with less cost and greater efficiency than historical ADC drug development.

Gwynne Shotwell Awarded the 2023 Green Sands Prize for Her Contributions to the Space Industry & STEM

Retrieved on: 
Wednesday, February 14, 2024

The 2023 Prize was focused on the Space industry.

Key Points: 
  • The 2023 Prize was focused on the Space industry.
  • Moreover, the industry has become a symbol of human aspiration, inspiring future generations to pursue science, technology, engineering, and mathematics (STEM) careers.
  • The committee unanimously selected Gwynne Shotwell as the 2023 recipient of the Inspiration Prize.
  • “Gwynne’s combination of symbolic significance, business acumen, and technical engineering made her the obvious winner of the Green Sands Prize in the Space Industry.

Yamaha Develops Hydrogen Fuel System with Roush and Regulator Marine, Hydrogen Outboard Unveiled at Miami International Boat Show®

Retrieved on: 
Wednesday, February 14, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240214748918/en/
    Yamaha Motor Corporation, U.S.A. today unveiled the world’s first hydrogen-powered outboard for recreational boats.
  • Yamaha joined forces with Roush to develop the fuel system for the outboard and collaborated with long-time boat builder partner Regulator Marine to build a boat suitable for testing the prototype outboard.
  • (Photo: Business Wire)
    Yamaha joined forces with Roush to develop the fuel system to power the new outboard and collaborated with long-time boat builder partner Regulator Marine to build a boat suitable for testing the prototype outboard.
  • Together, Yamaha, Regulator and Roush displayed the boat hull, fuel system and outboard to demonstrate how hydrogen could work as a possible fuel source in a marine environment.